Agentic AI In Healthcare Market to Grow with a CAGR of 7.08% through 2030
Surge in research and development activities is
expected to drive the Global Agentic AI In Healthcare Market growth in the
forecast period, 2026-2030.
According to TechSci Research report, “Agentic AI
In Healthcare Market - Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Agentic AI In Healthcare
Market stood at USD 176.21 Million in 2024 and is anticipated to grow with a
CAGR of 7.08% through 2030. Initiatives taken by government based on agentic AI
in healthcare has led to favorable market conditions for the Global Agentic AI
In Healthcare Market. Several factors contribute to the growth of various agentic
AI in healthcare products.
One of the main drivers behind this surge in R&D
is the growing recognition of the potential of Agentic AI to address pressing
challenges in healthcare. From improving diagnostic accuracy to optimizing
treatment plans and enhancing patient engagement, Agentic AI offers solutions
that can significantly improve the quality and efficiency of care. As a result,
research efforts are focused on advancing the capabilities of these systems,
particularly in areas such as medical imaging, predictive analytics, and
personalized medicine. AI algorithms are being developed to autonomously
analyze vast amounts of patient data—such as medical records, genetic
information, and real-time vital signs—and make decisions that are more precise
and tailored to individual needs.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Agentic AI In Healthcare Market”
Regulatory frameworks are another critical government
initiative to facilitate the integration of Agentic AI into healthcare.
Governments are working closely with regulatory bodies, such as the U.S. Food
and Drug Administration (FDA) and the European Medicines Agency (EMA), to
establish guidelines for the safe and effective use of AI-driven healthcare
solutions. These frameworks ensure that AI technologies meet safety, efficacy,
and ethical standards, providing confidence to healthcare providers and
patients in their adoption. The FDA, for example, has introduced specific
guidelines for AI-powered medical devices, including those used for diagnostics
and surgical assistance, to streamline the approval process and accelerate the
deployment of AI technologies in clinical settings.
The Global Agentic AI In Healthcare Market is
segmented into product, application, regional distribution, and company.
Based on Product, Multi Agent Systems have
emerged as the dominating segment in the Global Agentic AI In Healthcare Market
in 2024. Multi-agent systems are highly adaptable and scalable, making them
ideal for evolving healthcare environments. As healthcare systems grow and
change, the number and scope of tasks requiring AI assistance also increase.
Multi-agent systems can easily scale by adding more agents, which can be
trained to perform specific tasks or address emerging healthcare needs. This
scalability allows healthcare organizations to quickly adjust their AI
capabilities as patient demand, data complexity, and operational requirements
evolve, providing long-term flexibility and growth potential.
Based on Region, Asia Pacific have emerged as the fastest
growing region in the Global Agentic AI In Healthcare Market in 2024. The Asia
Pacific region is home to some of the world’s most populous countries, such as
China, India, and Japan, where the demand for healthcare services is rapidly
increasing. The rising prevalence of chronic diseases, an aging population, and
a growing middle class are placing significant pressure on healthcare systems.
AI technologies, including agentic AI in healthcare, provide a means to
alleviate these challenges by improving the efficiency and effectiveness of
healthcare delivery. Agentic AI systems, which can autonomously support
decision-making, play a crucial role in enhancing diagnostic accuracy and
patient care while reducing the workload of healthcare providers.
Major companies operating in Global Agentic AI In
Healthcare Market are:
- NVIDIA Corporation
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Thoughtful Automation Inc.
- Hippocratic AI Inc.
- Cognigy GmbH
- Amelia US LLC
- Beam AI Inc.
- Mindsprint Pte. Ltd.
- Hyro AI Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Nanotechnology enables the development of
nanoparticles that can target specific cells or tissues within the body, making
it possible to detect diseases at much earlier stages. When combined with AI,
these nanoparticles can be programmed to identify biomarkers associated with
various health conditions, such as cancer, cardiovascular diseases, and
neurodegenerative disorders. Agentic AI systems can then analyze the data from
these nanoparticles, allowing for highly accurate and personalized diagnostics”,
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Agentic AI In Healthcare Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2020-2030F Segmented By Product
(Ready-to-Deploy Agents, Multi Agent Systems), By Application (Medical Imaging,
Personalized Treatment & Drug Discovery, Electronic Health Records (EHR),
Remote Patient Care, Genomic Data Analysis, Chronic Disease Management,
Others), By Region and Competition”, has evaluated the future growth potential of Global
Agentic AI In Healthcare Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Agentic
AI In Healthcare Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com